Experienced in IgG4-Related Disease

Dr. Allison C. Rosenthal

Hematology Oncology | Hematology
Mayo Clinic
Mayo Clinic Arizona
5701 E Mayo Blvd, 
Phoenix, AZ 
Offers Telehealth
16 Years of Experience

Experienced in IgG4-Related Disease
Mayo Clinic
Mayo Clinic Arizona
5701 E Mayo Blvd, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Allison Rosenthal is a Hematologist Oncology specialist and a Hematologist in Phoenix, Arizona. Dr. Rosenthal has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of IgG4-Related Disease.

Graduate Year
2009
Specialties
Hematology Oncology
Hematology
Licenses
Internal Medicine in AZ
Hospital Affiliations
Mayo Clinic Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

MAYO CLINIC ARIZONA
5701 E Mayo Blvd, Phoenix, AZ 85054
Call: 480-342-4200
Other Locations
MAYO CLINIC ARIZONA
5777 E Mayo Blvd, Mayo Clinic Hospital, Phoenix, AZ 85054
Call: 800-603-0558
MAYO CLINIC ARIZONA
13400 E Shea Blvd, Scottsdale, AZ 85259
Call: 480-301-8000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Phase I/Ib Open-label, Multi-center Dose Escalation Study of JBH492 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
A Phase I/Ib Open-label, Multi-center Dose Escalation Study of JBH492 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Enrollment Status: Terminated
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: JBH492 Anti-CCR7 Antibody-Drug Conjugate
Study Phase: Phase 1
A Phase I Study With an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS)
A Phase I Study With an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS)
Enrollment Status: Active_not_recruiting
Publish Date: September 25, 2025
Intervention Type: Drug, Biological, Procedure
Study Drugs: Duvelisib, Nivolumab
Study Phase: Phase 1
Phase I/Ib Study of Parsaclisib (INCB50465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (PaR-CHOP) Immunochemotherapy for Patients With Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma
Phase I/Ib Study of Parsaclisib (INCB50465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (PaR-CHOP) Immunochemotherapy for Patients With Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: September 10, 2025
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Parsaclisib, Pegfilgrastim, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 1
A Phase Ia/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients With CLL/SLL or Non-Hodgkin's Lymphomas
A Phase Ia/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients With CLL/SLL or Non-Hodgkin's Lymphomas
Enrollment Status: Terminated
Publish Date: March 07, 2025
Intervention Type: Drug
Study Drug: CG-806
Study Phase: Phase 1
Phase II Expansion Cohorts Studies of a Novel Triple Combination Therapy, DTRM-555, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Non-Hodgkin's Lymphomas
Phase II Expansion Cohorts Studies of a Novel Triple Combination Therapy, DTRM-555, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Non-Hodgkin's Lymphomas
Enrollment Status: Terminated
Publish Date: January 08, 2025
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 2
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Biological, Drug
Study Drugs: Polatuzumab Vedotin, Rituximab, Hyaluronidase Human, Venetoclax
Study Phase: Phase 2
A Phase Ia/Ib Study of a Novel BTK Inhibitor, DTRMWXHS-12, and Combination Products, DTRM-505 and DTRM-555, in Patients With Chronic Lymphocytic Leukemia or Other B-cell Lymphomas
A Phase Ia/Ib Study of a Novel BTK Inhibitor, DTRMWXHS-12, and Combination Products, DTRM-505 and DTRM-555, in Patients With Chronic Lymphocytic Leukemia or Other B-cell Lymphomas
Enrollment Status: Completed
Publish Date: November 27, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

109 Total Publications

Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.
Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.
Journal: Cancers
Published: September 16, 2025
View All 109 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Devinder P. Singh
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Devinder P. Singh
Hematology Oncology | Hematology | Oncology

Honorhealth Ambulatory

5750 W Thunderbird Rd, Suite C300, 
Glendale, AZ 
 (13.2 miles away)
855-485-4673
Languages Spoken:
English, Hindi, Punjabi
See accepted insurances
Accepting New Patients
Offers Telehealth

Devinder Singh is a Hematologist Oncology specialist and a Hematologist in Glendale, Arizona. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Waldenstrom Macroglobulinemia, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Large-Cell Immunoblastic Lymphoma. Dr. Singh is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Joan M. Dahmer
Hematology Oncology | Hematology
Experienced in IgG4-Related Disease
Dr. Joan M. Dahmer
Hematology Oncology | Hematology

Honorhealth Ambulatory

10460 N 92nd St, Suite 200, 
Scottsdale, AZ 
 (6.8 miles away)
855-485-4673
Languages Spoken:
English, French, German, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Joan Dahmer is a Hematologist Oncology specialist and a Hematologist in Scottsdale, Arizona. Dr. Dahmer is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Dahmer is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Rohan Sharma
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Rohan Sharma
Hematology Oncology | Hematology | Oncology

Honorhealth Ambulatory

9003 E Shea Blvd, Suite Hg, 
Scottsdale, AZ 
 (6.7 miles away)
480-323-4973
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rohan Sharma is a Hematologist Oncology specialist and a Hematologist in Scottsdale, Arizona. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Acute Mountain Sickness, Idiopathic Pulmonary Hemosiderosis, Hemosiderosis, Pulmonary Embolism, and Carotid Artery Surgery. Dr. Sharma is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
  • Elite
  • B-Cell Lymphoma
    Dr. Rosenthal is
    Elite
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Diffuse Large B-Cell Lymphoma (DLBCL)
    Dr. Rosenthal is
    Elite
    . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
    See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
  • Non-Hodgkin Lymphoma
    Dr. Rosenthal is
    Elite
    . Learn about Non-Hodgkin Lymphoma.
    See more Non-Hodgkin Lymphoma experts
  • Distinguished
  • Bone Marrow Transplant
    Dr. Rosenthal is
    Distinguished
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Chronic B-Cell Leukemia (CBCL)
    Dr. Rosenthal is
    Distinguished
    . Learn about Chronic B-Cell Leukemia (CBCL).
    See more Chronic B-Cell Leukemia (CBCL) experts
  • Chronic Lymphocytic Leukemia (CLL)
    Dr. Rosenthal is
    Distinguished
    . Learn about Chronic Lymphocytic Leukemia (CLL).
    See more Chronic Lymphocytic Leukemia (CLL) experts
  • Classical Hodgkin Lymphoma
    Dr. Rosenthal is
    Distinguished
    . Learn about Classical Hodgkin Lymphoma.
    See more Classical Hodgkin Lymphoma experts
  • Cutaneous T-Cell Lymphoma (CTCL)
    Dr. Rosenthal is
    Distinguished
    . Learn about Cutaneous T-Cell Lymphoma (CTCL).
    See more Cutaneous T-Cell Lymphoma (CTCL) experts
  • Follicular Lymphoma
    Dr. Rosenthal is
    Distinguished
    . Learn about Follicular Lymphoma.
    See more Follicular Lymphoma experts
View All 19 Distinguished Conditions
  • Advanced
  • Angioimmunoblastic T-cell Lymphoma
    Dr. Rosenthal is
    Advanced
    . Learn about Angioimmunoblastic T-cell Lymphoma.
    See more Angioimmunoblastic T-cell Lymphoma experts
  • Burkitt Lymphoma
    Dr. Rosenthal is
    Advanced
    . Learn about Burkitt Lymphoma.
    See more Burkitt Lymphoma experts
  • Marginal Zone Lymphoma (MZL)
    Dr. Rosenthal is
    Advanced
    . Learn about Marginal Zone Lymphoma (MZL).
    See more Marginal Zone Lymphoma (MZL) experts
  • Myelofibrosis
    Dr. Rosenthal is
    Advanced
    . Learn about Myelofibrosis.
    See more Myelofibrosis experts
  • Primary Amyloidosis
    Dr. Rosenthal is
    Advanced
    . Learn about Primary Amyloidosis.
    See more Primary Amyloidosis experts
  • Primary Mediastinal B-Cell Lymphoma (PMBCL)
    Dr. Rosenthal is
    Advanced
    . Learn about Primary Mediastinal B-Cell Lymphoma (PMBCL).
    See more Primary Mediastinal B-Cell Lymphoma (PMBCL) experts
View All 10 Advanced Conditions
  • Experienced
  • Activated PI3K Delta Syndrome (APDS)
    Dr. Rosenthal is
    Experienced
    . Learn about Activated PI3K Delta Syndrome (APDS).
    See more Activated PI3K Delta Syndrome (APDS) experts
  • Acute Eosinophilic Pneumonia
    Dr. Rosenthal is
    Experienced
    . Learn about Acute Eosinophilic Pneumonia.
    See more Acute Eosinophilic Pneumonia experts
  • Acute Myelomonocytic Leukemia
    Dr. Rosenthal is
    Experienced
    . Learn about Acute Myelomonocytic Leukemia.
    See more Acute Myelomonocytic Leukemia experts
  • Adult Immune Thrombocytopenia
    Dr. Rosenthal is
    Experienced
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Agranulocytosis
    Dr. Rosenthal is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Rosenthal is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
View All 92 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved